Martin Knight | Sr. Director, Strategy & Planning, Inflammation, Infectious Disease and General Medicine

Martin Knight, Sr. Director, Strategy & Planning, Inflammation, Infectious Disease and General Medicine, Covance

Martin Knight is a Senior Director, Strategy & Planning, based in the UK, and has 30 years’ experience within the pharmaceutical industry. Within his current role, Martin is responsible for supporting project teams in developing the appropriate strategy for conducting studies within the Inflammation, Infectious Disease & General Medicine (iiGM) therapeutic area with additional focus upon biosimilars. This includes leading feasibility assessments, data analysis, subsequent data modelling, assessing study risks and challenges and ultimately recommending the geographic placement for clinical studies. 
Martin obtained his degree in Pharmacology from the University of Manchester in 1987 and a Post-Graduate Diploma in Clinical Science from the University of Wales, Cardiff in 1997. Martin has a background in Project Management having held positions as a Global Project Director, Director of Clinical Operations, Client Relationship Director and Senior Director, Project Management before moving into Strategy and Planning in 2007.


Biosimilars Day 1 - Tuesday 31st October 2017 @ 15:10

Patient Recruitment in Biosimilar Studies - Challenges and Solutions 

  •     What are the key challenges we face?
  •     What do we need to do differently to achieve recruitment goals?
  •     How can we utilise data to aid recruitment?

back to speakers